Sun Pharmaceutical Industries, one of the leading drug manufacturers globally, is making significant strides to address regulatory challenges posed by the US Food and Drug Administration (USFDA) at three of its facilities. Read more: https://www.hrpf.us/webinars/corrective-actions-preventive-actions-capa-101